Cencora Inc (NYSE: COR) on Tuesday, plunged -0.78% from the previous trading day, before settling in for the closing price of $242.87. Within the past 52 weeks, COR’s price has moved between $194.56 and $251.56.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 10.39% annually for the last half of the decade. The company achieved an average annual earnings per share of 8.58%. With a float of $176.38 million, this company’s outstanding shares have now reached $200.81 million.
In an organization with 46000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 3.06%, operating margin of 0.84%, and the pretax margin is 0.68%.
Cencora Inc (COR) Insider Updates
Observing investor behavior towards Medical Distribution industry stocks is more important than anything else. The insider ownership of Cencora Inc is 10.49%, while institutional ownership is 89.79%. The most recent insider transaction that took place on Nov 19 ’24, was worth 5,208,619. Before that another transaction happened on Oct 22 ’24, when Company’s Executive Chairman sold 21,509 for $235.80, making the entire transaction worth $5,071,822. This insider now owns 285,088 shares in total.
Cencora Inc (COR) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported 3.28 earnings per share (EPS) for the period topping the consensus outlook (set at 2.89) by 0.39. Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.43% during the next five years compared to 13.27% growth over the previous five years of trading.
Cencora Inc (NYSE: COR) Trading Performance Indicators
Cencora Inc (COR) is currently performing well based on its current performance indicators. A quick ratio of 0.51 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.16. Likewise, its price to free cash flow for the trailing twelve months is 15.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.51, a number that is poised to hit 3.50 in the next quarter and is forecasted to reach 16.33 in one year’s time.
Technical Analysis of Cencora Inc (COR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.33 million. That was inferior than the volume of 1.41 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 36.12%. Additionally, its Average True Range was 4.62.
During the past 100 days, Cencora Inc’s (COR) raw stochastic average was set at 67.85%, which indicates a significant increase from 55.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.86% in the past 14 days, which was higher than the 18.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $232.82, while its 200-day Moving Average is $233.13. However, in the short run, Cencora Inc’s stock first resistance to watch stands at $243.11. Second resistance stands at $245.23. The third major resistance level sits at $246.54. If the price goes on to break the first support level at $239.68, it is likely to go to the next support level at $238.37. Assuming the price breaks the second support level, the third support level stands at $236.25.
Cencora Inc (NYSE: COR) Key Stats
Market capitalization of the company is 47.48 billion based on 197,047K outstanding shares. Right now, sales total 293,959 M and income totals 1,509 M. The company made 79,050 M in profit during its latest quarter, and 3,380 K in sales during its previous quarter.
